Market Tracker

08/31 5:16pm ET

Galena Biopharma Inc (NASDAQ:GALE)

0.4043
Delayed Data
As of 4:00pm ET
 -0.0072 / -1.75%
Today’s Change
0.28
Today|||52-Week Range
2.49
-72.50%
Year-to-Date

Today’s Trading

Previous close0.41
Today’s open0.41
Day’s range0.40 - 0.41
Volume2,816,582
Average volume (3 months)6,605,681
Market cap$88.0M
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)-23.32%
Earnings growth (this year)+60.98%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.00-0.03%
NNVCNanoViricides Inc-0.03-1.95%
CEMIChembio Diagnostics ...-0.11-1.52%
ATNMActinium Pharmaceuti...-0.01-0.55%
Data as of 4:02pm ET, 08/31/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$59.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
San Ramon, California

Forecasts